Internal Medicine Alert – May 15, 2007
May 15, 2007
View Issues
-
Reynolds Risk Score: An Update to Cardiovascular Risk Assessment in Women
For women, up to 20% of all coronary events occur in the absence of traditional major risk factors, and many women with these risk factors do not develop coronary events. -
Score One for the Kidneys
A simple questionnaire can identify individuals at risk for chronic kidney disease. -
What is the Optimal Dosing for Unfractionated Heparin?
Patients at high risk for VTE should be treated with three times daily UH, while patients at lower risk may be treated with twice daily therapy. -
Vorinostat Capsules (Zolinza™)
A new class of drug has been approved for the treatment of cutaneous T-cell lymphoma (CTCL) such as mycosis fungoides. -
Clinical Briefs By Louis Kuritzky, MD
Persons who do not suffer hyperhidrosis (HID) may be surprised to learn that it has been associated with both occupational and physical impairment, as well as limitations in social interaction. -
ECG Review: Can It Wait until after X-Mas?
The ECG Figure in the article was obtained from an older woman who was seen in the Emergency Department with a chief complaint of weakness of several days duration. -
Pharmacology Watch
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.